Cargando…
Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs
Combretastatin A-4 (CA-4, 1) is an antimicrotubule agent used as a prototype for the design of several synthetic analogues with anti-tubulin activity, such as LASSBio-1586 (2). A series of branched and unbranched homologs of the lead-compound 2, and vinyl, ethinyl and benzyl analogues, were designed...
Autores principales: | Barbosa, Gisele, Gelves, Luis Gabriel Valdivieso, Costa, Caroline Marques Xavier, Franco, Lucas Silva, de Lima, João Alberto Lins, Aparecida-Silva, Cristiane, Teixeira, John Douglas, Mermelstein, Claudia dos Santos, Barreiro, Eliezer J., Lima, Lidia Moreira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394307/ https://www.ncbi.nlm.nih.gov/pubmed/35893736 http://dx.doi.org/10.3390/ph15080913 |
Ejemplares similares
-
LASSBio-1586, an N-acylhydrazone derivative, attenuates nociceptive behavior and the inflammatory response in mice
por: Silva, Juliane Cabral, et al.
Publicado: (2018) -
Design and Synthesis In Silico Drug-like Prediction and Pharmacological Evaluation of Cyclopolymethylenic Homologous of LASSBio-1514
por: Lima, Lidia Moreira, et al.
Publicado: (2021) -
Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema
por: Padilha, Gisele A., et al.
Publicado: (2015) -
Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity
por: de Queiroz, Aline Cavalcanti, et al.
Publicado: (2022) -
Analgesic and Anti-Inflammatory Activities of Salicylaldehyde 2-Chlorobenzoyl Hydrazone (H(2)LASSBio-466), Salicylaldehyde 4-Chlorobenzoyl Hydrazone (H(2)LASSBio-1064) and Their Zinc(II) Complexes
por: Júnior, Walfrido Bispo, et al.
Publicado: (2011)